Vascular risk factors, cognitve decline, and dementia

References

• ADVANCERationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled EvaluationJ Hypertens Suppl200119S218
   Google Scholar
• AkomolafeABeiserAMeigsJBDiabetes mellitus and risk of developing Alzheimer disease: results from the Framingham StudyArch Neurol2006631551517101823
   PubMed Web of Science ®Google Scholar
• AkiyamaHBargerSBarnumSInflammation and Alzheimer’s diseaseNeurobiol Aging20002138342110858586
   PubMed Web of Science ®Google Scholar
• AllenKVFrierBMStrachanMWThe relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitationsEur J Pharmacol20044901697515094083
   PubMed Web of Science ®Google Scholar
• AnsteyKJvon SandenCSalimASmoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studiesAm J Epidemiol20071663677817573335
   PubMed Web of Science ®Google Scholar
• ArreguiAPerryEKRossorMAngiotensin converting enzyme in Alzheimer’s disease increased activity in caudate nucleus and cortical areasJ Neurochem198238149026278093
   PubMed Web of Science ®Google Scholar
• ArvanitakisZWilsonRSBieniasJLDiabetes mellitus and risk of Alzheimer disease and decline in cognitive functionArch Neurol200461661615148141
   PubMed Web of Science ®Google Scholar
• BeeriMSRappMSilvermanJMCoronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriersNeurology200666139940416682673
   PubMed Web of Science ®Google Scholar
• BellewKMPigeonJGStangPEHypertension and the rate of cognitive decline in patients with dementia of the Alzheimer typeAlzheimer Dis Assoc Disord2004182081315592132
   PubMed Web of Science ®Google Scholar
• BenoitSCCleggDJSeeleyRJInsulin and leptin as adiposity signalsRecent Prog Horm Res2004592678514749506
   PubMedGoogle Scholar
• BernickCKatzRSmithNLCardiovascular Health Study Collaborative Research Group. Statins and cognitive function in the elderly: the Cardiovascular Health StudyNeurology20056513889416275825
   PubMed Web of Science ®Google Scholar
• BiesselsGJStaekenborgSBrunnerERisk of dementia in diabetes mellitus: a systematic reviewLancet Neurol20065647416361024
   PubMed Web of Science ®Google Scholar
• BirkenhagerWHStaessenJAProgress in cardiovascular diseases: cognitive function in essential hypertensionProg Cardiovasc Dis20064911016867845
   PubMed Web of Science ®Google Scholar
• BirnsJMorrisRDonaldsonNThe effects of blood pressure reduction on cognitivefunction: a review of effects based on pooled data from clinical trialsJ Hypertens20062419071416957545
   PubMed Web of Science ®Google Scholar
• BlackerDHainesJLRodesLApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiativeNeurology199748139479008509
   PubMed Web of Science ®Google Scholar
• BodovitzSKleinWLCholesterol modulates alpha-secretase cleavage of amyloid precursor proteinJ Biol Chem19962714436408626795
   PubMed Web of Science ®Google Scholar
• BohannonADFillenbaumGGPieperCFRelationship of race/ethnicity and blood pressure to change in cognitive functionJ Am Geriatr Soc200250424911943035
   PubMed Web of Science ®Google Scholar
• BondyCAChengCMSignaling by insulin-like growth factor 1 in brainEur J Pharmacol2004490253115094071
   PubMed Web of Science ®Google Scholar
• BoschJYusufSPogueJHOPE InvestigatorsHeart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trialBMJ200232469970211909785
   PubMed Web of Science ®Google Scholar
• BrandsAMBiesselsGJde HaanEHThe effects of type 1 diabetes on cognitive performance: a meta-analysisDiabetes Care2005287263515735218
   PubMed Web of Science ®Google Scholar
• CacciatoreFAbetePFerraraNOsservatorio Geriatrico Campano Study GroupCongestive heart failure and cognitive impairment in an older populationJ Am Geriatr Soc199846134389809754
   PubMed Web of Science ®Google Scholar
• CasserlyITopolEConvergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteinsLancet200436311394615064035
   PubMed Web of Science ®Google Scholar
• CowieMRMosterdAWoodDAThe epidemiology of heart failureEur Heart J199718208259043837
   PubMed Web of Science ®Google Scholar
• CruickshankJMNeil-DwyerGDorranceDEAcute effects of smoking on blood pressure and cerebral blood flowJ Hum Hypertens1989344392691689
   PubMed Web of Science ®Google Scholar
• CummingsJLAlzheimer’s diseaseN Engl J Med2004351566715229308
   PubMed Web of Science ®Google Scholar
• CurbJDRodriguezBLAbbottRDLongitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose toleranceNeurology199952971510102414
   PubMed Web of Science ®Google Scholar
• DavignonJGreggRESingCFApolipoprotein E polymorphism and atherosclerosisArteriosclerosis198881213277611
   PubMedGoogle Scholar
• DebetteSBomboisSBruandetASubcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairmentStroke20073829243017885256
   PubMed Web of Science ®Google Scholar
• de la TorreJCIs Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialecticsLancet Neurol200431849014980533
   PubMed Web of Science ®Google Scholar
• de la TorreJCHow do heart disease and stroke become risk factors for Alzheimer’s disease?Neurol Res2006286374416945216
   PubMed Web of Science ®Google Scholar
• de LeeuwFERichardFde GrootJCInteraction between hypertension, apoE, and cerebral white matter lesionsStroke20043510576015060316
   PubMed Web of Science ®Google Scholar
• Di BariMPahorMFranseLVDementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trialAm J Epidemiol200115372811159149
   PubMed Web of Science ®Google Scholar
• DikMGJonkerCComijsHCContribution of metabolic syndrome components to cognition in older personsDiabetes Care20073026556017563341
   PubMed Web of Science ®Google Scholar
• DufouilCChalmersJCoskunOPROGRESS MRI Substudy InvestigatorsEffects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging SubstudyCirculation200511216445016145004
   PubMed Web of Science ®Google Scholar
• DufouilCRichardFFievetNAPOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City StudyNeurology2005641531815883313
   PubMed Web of Science ®Google Scholar
• EdlandSDRoccaWAPetersenRCDementia and Alzheimer disease incidence rates do not vary by sex in Rochester, MinnArch Neurol20025915899312374497
   PubMed Web of Science ®Google Scholar
• EichnerJEDunnSTPerveenGApolipoprotein E polymorphism and cardiovascular disease: a HuGE reviewAm J Epidemiol20021554879511882522
   PubMed Web of Science ®Google Scholar
• EliasMFWolfPAD’AgostinoRBUntreated blood pressure level is inversely related to cognitive functioning: the Framingham StudyAm J Epidemiol1993138353648213741
   PubMed Web of Science ®Google Scholar
• EtminanMGillSSamiiAEffect of non-steroidal anti – inflammatory drugs on risk of Alzheimer’s disease: systematic review and meta-analysis of observational studiesBMJ20031912812869452
   PubMedGoogle Scholar
• EvansRMEmsleyCLGaoSSerum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: a population-based study of African AmericansNeurology200054240210636159
   PubMed Web of Science ®Google Scholar
• Expert Panel Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• FarmerMEWhiteLRAbbottRDBlood pressure and cognitive performance. The Framingham StudyAm J Epidemiol19871261103143687920
   PubMed Web of Science ®Google Scholar
• FarrerLACupplesLAHainesJLEffects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA19972781349569343467
   PubMed Web of Science ®Google Scholar
• FassbenderKSimonsMBergmannCSimvastatin strongly reduces levels of Alzheimer’s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivoProc Natl Acad Sci USA20019858566111296263
   PubMed Web of Science ®Google Scholar
• FeiginVRatnasabapathyYAndersonCDoes blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?J Neurol Sci2005229230151515760634
   PubMedGoogle Scholar
• FerriCPPrinceMBrayneCAlzheimer’s Disease International. Global prevalence of dementia: a Delphi consensus studyLancet20053662112716360788
   PubMed Web of Science ®Google Scholar
• ForetteFSeuxMLStaessenJAPrevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialLancet19983521347519802273
   PubMed Web of Science ®Google Scholar
• ForetteFSeuxMLStaessenJASystolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) studyArch Intern Med200216220465212374512
   PubMed Web of Science ®Google Scholar
• FortiPMaioliFPisacaneNAtrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI)Arch Gerontol Geriatr2007441556517317449
   PubMed Web of Science ®Google Scholar
• FreitagMHPeilaRMasakiKMidlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging StudyStroke20063733716339468
   PubMed Web of Science ®Google Scholar
• GaspariniLXuHPotential roles of insulin and IGF-1 in Alzheimer’s diseaseTrends Neurosci200326404612900169
   PubMed Web of Science ®Google Scholar
• GlynnRJBeckettLAHebertLECurrent and remote blood pressure and cognitive declineJAMA1999281438459952204
   PubMed Web of Science ®Google Scholar
• GorospeECDaveJKThe risk of dementia with increased body mass indexAge Ageing20073623917124253
   PubMed Web of Science ®Google Scholar
• GravesABvan DuijnCMChandraVEURODEM Risk Factors Research GroupAlcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studiesInt J Epidemiol199120S48571833354
   PubMed Web of Science ®Google Scholar
• GuoZViitanenMFratiglioniLLow blood pressure and dementia in elderly people: the Kungsholmen projectBMJ199631280588608286
   PubMed Web of Science ®Google Scholar
• GuoZFratiglioniLWinbladBBlood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen ProjectAm J Epidemiol19971451106139199540
   PubMed Web of Science ®Google Scholar
• GuoZFratiglioniLZhuLOccurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication useArch Neurol199958991610448805
   PubMedGoogle Scholar
• GustafsonDRothenbergEBlennowKAn 18-year follow-up of overweight and risk of Alzheimer diseaseArch Intern Med20031631524812860573
   PubMed Web of Science ®Google Scholar
• GustafsonDAdiposity indices and dementiaLancet Neurol200657132016857578
   PubMed Web of Science ®Google Scholar
• HajjarISchumpertJHirthVThe impact of the use of statins on the prevalence of dementia and the progression of cognitive impairmentJ Gerontol A Biol Sci Med Sc2002574148
   PubMed Web of Science ®Google Scholar
• HanonOHaulonSLenoirHRelationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory lossStroke2005a362193716151027
   PubMed Web of Science ®Google Scholar
• HanonOLatourFSeuxMLF; REAL.FR GroupEvolution of blood pressure in patients with Alzheimer’s disease: a one year survey of a French Cohort (REAL.FR)J Nutr Health Aging2005b91061115791354
   PubMed Web of Science ®Google Scholar
• HanonOPequignotRSeuxMLRelationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaintsJ Hypertens2006242101716957572
   PubMed Web of Science ®Google Scholar
• HardyJAMannDMWesterPAn integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s diseaseNeurobiol Aging198674895022882432
   PubMed Web of Science ®Google Scholar
• HarrisMIDiabetes in America: epidemiology and scope of the problemDiabetes Care199821Suppl 3C1149850480
   PubMed Web of Science ®Google Scholar
• HassingLBJohanssonBNilssonSEDiabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer’s disease: a population-based study of the oldest oldInt Psychogeriatr2002142394812475085
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
   PubMed Web of Science ®Google Scholar
• HeckbertSRLongstrethWTJrPsatyBMThe association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adultsJ Am Geriatr Soc1997451423339400550
   PubMed Web of Science ®Google Scholar
• HofmanAOttABretelerMMAtherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam StudyLancet199734915149111537
   PubMed Web of Science ®Google Scholar
• HsuehWGenetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer’s diseasePharmacogenomics J20066222416865098
   PubMed Web of Science ®Google Scholar
• JansonJLaedtkeTParisiJEIncreased risk of type 2 diabetes in Alzheimer diseaseDiabetes2004534748114747300
   PubMed Web of Science ®Google Scholar
• JickHZornbergGLJickSSStatins and the risk of dementiaLancet200035616273111089820
   PubMed Web of Science ®Google Scholar
• KalariaRNHederaPbeta-Amyloid vasoactivity in Alzheimer’s diseaseLancet1996347149238676667
   PubMedGoogle Scholar
• KalariaRNThe role of cerebral ischemia in Alzheimer’s diseaseNeurobiol Aging2000213213010867217
   PubMed Web of Science ®Google Scholar
• KalariaRSimilarities between Alzheimer’s disease and vascular dementiaJ Neurol Sci2002203–2042934
   PubMed Web of Science ®Google Scholar
• KalmijnSFoleyDWhiteLMetabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging studyArterioscler Thromb Vasc Biol20002022556011031212
   PubMed Web of Science ®Google Scholar
• KangJHCookNMansonJLow dose aspirin and cognitive function in the women’s health study cognitive cohortBMJ200733498717468120
   PubMedGoogle Scholar
• KhachaturianASZandiPPLyketsosCGAntihypertensive medication use and incident Alzheimer disease: the Cache County StudyArch Neurol2006636869216533956
   PubMed Web of Science ®Google Scholar
• KilanderLNymanHBobergMHypertension is related to cognitive impairment: a 20-year follow-up of 999 menHypertension1998a3178069495261
   PubMed Web of Science ®Google Scholar
• KilanderLAndrenBNymanHAtrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly menStroke1998b291816209731601
   PubMed Web of Science ®Google Scholar
• KivipeltoMHelkalaELLaaksoMPMidlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based studyBMJ200132214475111408299
   PubMed Web of Science ®Google Scholar
• KivipeltoMHelkalaELLaaksoMPApolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer diseaseAnn Intern Med20021371495512160362
   PubMed Web of Science ®Google Scholar
• KivipeltoMNganduTLaatikainenTRisk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based studyLancet Neurol200657354116914401
   PubMed Web of Science ®Google Scholar
• KnopmanDBolandLLMosleyTAtherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adultsNeurology20015642811148234
   PubMed Web of Science ®Google Scholar
• KölschHHeunRKerksiekAAltered levels of plasma 24S- and 27-hydroxycholesterol in demented patientsNeurosci Lett2004368303815364416
   PubMed Web of Science ®Google Scholar
• KumariMBrunnerEFuhrerRMinireview: mechanisms by which the metabolic syndrome and diabetes impair memoryJ Gerontol A Biol Sci Med Sci20005B2283210819309
   PubMedGoogle Scholar
• KuusistoJKoivistoKMykkanenLAssociation between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based studyBMJ1997315104599366728
   PubMed Web of Science ®Google Scholar
• KwonHMKimBJLeeSHMetabolic syndrome as an independent risk factor of silent brain infarction in healthy peopleStroke2006374667016373631
   PubMed Web of Science ®Google Scholar
• LaunerJMasakiKPetrovitchHThe association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging StudyJAMA19952741846517500533
   PubMed Web of Science ®Google Scholar
• LaunerLJRossGWPetrovitchHMidlife blood pressure and dementia: the Honolulu-Asia aging studyNeurobiol Aging200021495510794848
   PubMed Web of Science ®Google Scholar
• LithellHHanssonLSkoogISCOPE Study GroupThe Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trialJ Hypertens2003218758612714861
   PubMed Web of Science ®Google Scholar
• LuchsingerJATangMXSternYDiabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohortAm J Epidemiol20011546354111581097
   PubMed Web of Science ®Google Scholar
• LuchsingerJATangMXSheaSHyperinsulinemia and risk of Alzheimer diseaseNeurology20046311879215477536
   PubMed Web of Science ®Google Scholar
• LuchsingerJAReitzCHonigLSAggregation of vascular risk factors and risk of incident Alzheimer diseaseNeurology2005655455116116114
   PubMed Web of Science ®Google Scholar
• LuchsingerJAReitzCPatelBRelation of diabetes to mild cognitive impairmentArch Neurol200764570517420320
   PubMed Web of Science ®Google Scholar
• LütjohannDPapassotiropoulosABjörkhemIPlasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patientsJ Lipid Res200041195810681402
   PubMed Web of Science ®Google Scholar
• MacKnightCRockwoodKAwaltEDiabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of Health and AgingDement Geriatr CognDisord2002147783
   PubMed Web of Science ®Google Scholar
• MarkesberyWROxidative stress hypothesis in Alzheimer’s diseaseFree Radic Biol Med199723134479165306
   PubMed Web of Science ®Google Scholar
• MartinsCAOulhajAde JagerCAAPOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear modelNeurology20056518889316380608
   PubMed Web of Science ®Google Scholar
• MasseIBordetRDeplanqueDLipid lowering agents are associated with a slower cognitive decline in Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry2005761624916291883
   PubMed Web of Science ®Google Scholar
• MaxwellCJHoganDBEblyEMCalcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and AgingCMAJ1999161501610497605
   PubMed Web of Science ®Google Scholar
• McGuinnessBToddSPassmorePThe effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular diseaseCochrane Database Syst Rev20062CD00403416625595
   PubMedGoogle Scholar
• MerchantCTangMXAlbertSThe influence of smoking on the risk of Alzheimer’s diseaseNeurology19995214081210227626
   PubMed Web of Science ®Google Scholar
• MielkeMMZandiPPSjogrenMHigh total cholesterol levels in late life associated with a reduced risk of dementiaNeurology20056416899515911792
   PubMed Web of Science ®Google Scholar
• MilesWRootHPsychologic tests applies to diabetic patientsArch Int Med1922307677
   Google Scholar
• MilionisHJWinderAFMikhailidisDPLipoprotein (a) and strokeJ Clin Pathol2000534879610961170
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEPetersenRCRisk of dementia in stroke–free patients diagnosed with atrial fibrillation: data from a community-based cohortEur Heart J2007281962717459900
   PubMed Web of Science ®Google Scholar
• MoroneyJTTangMXBerglundLLow-density lipoprotein cholesterol and the risk of dementia with strokeJAMA19992822546010422994
   PubMed Web of Science ®Google Scholar
• MorrisMCScherrPAHebertLEAssociation of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community studyArch Neurol2001581640611594923
   PubMedGoogle Scholar
• MooserVHelbecqueNMiklossyJInteractions between apolipoprotein E and apolipoprotein (a) in patients with late-onset Alzheimer diseaseAnn Intern Med2000132533710744589
   PubMed Web of Science ®Google Scholar
• MurrayMDLaneKAGaoSPreservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African AmericansArch Intern Med20021622090612374517
   PubMed Web of Science ®Google Scholar
• NewmanABFitzpatrickALLopezODementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohortJ Am Geriatr Soc2005531101716108925
   PubMed Web of Science ®Google Scholar
• NilssonSEJohanssonBTakkinenSDoes aspirin protect against Alzheimer’s dementia? A study in a Swedish population-based sample aged ≥80 yearsEur J Clin Pharmacol200359313912827329
   PubMed Web of Science ®Google Scholar
• NotkolaILSulkavaRPekkanenJSerum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s diseaseNeuroepidemiology19981714209549720
   PubMed Web of Science ®Google Scholar
• O’ConnellJEGrayCSFrenchJMAtrial fibrillation and cognitive function: case-control studyJ Neurol Neurosurg Psychiatry19986538699728958
   PubMed Web of Science ®Google Scholar
• OkumiyaKMatsubayashiKWadaTJ-curve relation between blood pressure and decline in cognitive function in older people living in community, JapanJ Am Geriatr Soc199745103239256863
   PubMed Web of Science ®Google Scholar
• OttABretelerMMde BruyneMCAtrial fibrillation and dementia in a population-based study. The Rotterdam StudyStroke199728316219040682
   PubMed Web of Science ®Google Scholar
• OttASlooterAJHofmanASmoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam StudyLancet1998351184039652667
   PubMed Web of Science ®Google Scholar
• OttAStolkRPvan HarskampFDiabetes mellitus and the risk of dementia: The Rotterdam StudyNeurology19995319374210599761
   PubMed Web of Science ®Google Scholar
• OttAAndersenKDeweyMEEURODEM Incidence Research GroupEffect of smoking on global cognitive function in nondemented elderlyNeurology200462920415037693
   PubMed Web of Science ®Google Scholar
• PanzaFD’IntronoAColaciccoAMVascular risk and genetics of sporadic late-onset Alzheimer’s diseaseJ Neural Transm2004111698914714217
   PubMed Web of Science ®Google Scholar
• PanzaFD’IntronoAColaciccoAMLipid metabolism in cognitive decline and dementiaBrain Res Rev2006512759216410024
   PubMed Web of Science ®Google Scholar
• PapassotiropoulosALütjohannDBagliMPlasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer’s diseaseNeuroreport20001119596210884051
   PubMed Web of Science ®Google Scholar
• PeilaRRodriguezBLLaunerLJHonolulu-Asia Aging StudyType 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging StudyDiabetes20025112566211916953
   PubMed Web of Science ®Google Scholar
• PeilaRWhiteLRMasakiKReducing the risk of dementia: efficacy of long-term treatment of hypertensionStroke20063711657016601212
   PubMed Web of Science ®Google Scholar
• PerlmutterLSBarronESaperiaDAssociation between vascular basement membrane components and the lesions of Alzheimer’s diseaseJ Neurosci Res199030673811787541
   PubMed Web of Science ®Google Scholar
• PfriegerFWCholesterol homeostasis and function in neurons of the central nervous systemCell Mol Life Sci20036011587112861382
   PubMed Web of Science ®Google Scholar
• PiguetOGraysonDACreaseyHVascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons StudyNeuroepidemiology2003221657112711848
   PubMed Web of Science ®Google Scholar
• PostiglioneACorteseCFischettiAPlasma lipids and geriatric assessment in a very aged population of south ItalyAtherosclerosis1989806382604758
   PubMed Web of Science ®Google Scholar
• PrinceMJBirdASBlizardRAIs the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s trial of hypertension in older adultsBMJ199631280158608285
   PubMed Web of Science ®Google Scholar
• PrinsNDvan DijkEJden HeijerTCerebral white matter lesions and the risk of dementiaArchNeurol20046115314
   Google Scholar
• PullicinoPMHartJCognitive impairment in congestive heart failure?: Embolism vs hypoperfusionNeurology2001571945611739807
   PubMed Web of Science ®Google Scholar
• QiuCWinbladBViitanenMPulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal studyStroke200334594912624277
   PubMed Web of Science ®Google Scholar
• QiuCWinbladBMarengoniAHeart failure and risk of dementia and Alzheimer disease: a population-based cohort studyArch Intern Med20061661003816682574
   PubMed Web of Science ®Google Scholar
• QiuWQFolsteinMFInsulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer’s disease: review and hypothesisNeurobiol Aging200627190816399206
   PubMed Web of Science ®Google Scholar
• RacchiMBaettaRSalviettiNSecretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol contentBiochem J199732289389148766
   PubMed Web of Science ®Google Scholar
• RazayGVreugdenhilAWilcockGThe metabolic syndrome and Alzheimer diseaseArch Neurol20076493617210814
   PubMedGoogle Scholar
• ReaTDBreitnerJCPsatyBMStatin use and the risk of incident dementia: the Cardiovascular Health StudyArch Neurol20056210475116009757
   PubMed Web of Science ®Google Scholar
• ReinesSABlockGAMorrisJCRofecoxib: no effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled studyNeurology200462667114718699
   PubMed Web of Science ®Google Scholar
• ReinprechtFElmstahlSJanzonLHypertension and changes of cognitive function in 81-year-old men: a 13-year follow-up of the population study “Men born in 1914”, SwedenJ Hypertens200321576612544436
   PubMed Web of Science ®Google Scholar
• ReitzCTangMXLuchsingerJRelation of plasma lipids to Alzheimer disease and vascular dementiaArch Neurol2004617051415148148
   PubMed Web of Science ®Google Scholar
• RennieKLJebbSAPrevalence of obesity in Great BritainObes Rev2005611215655034
   PubMed Web of Science ®Google Scholar
• RomasSNTangMXBerglundLAPOE genotype, plasma lipids, lipoproteins, and AD in community elderlyNeurology1999535172110449113
   PubMed Web of Science ®Google Scholar
• RosengrenASkoogIGustafsonDBody mass index, other cardiovascular risk factors, and hospitalization for dementiaArch Intern Med2005165321615710796
   PubMed Web of Science ®Google Scholar
• SabatiniTFrisoniGBBarbisoniPAtrial fibrillation and cognitive disorders in older peopleJ Am Geriatr Soc2000483879010798464
   PubMed Web of Science ®Google Scholar
• SaundersAMStrittmatterWJSchmechelDAssociation of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s diseaseNeurology1993431467728350998
   PubMed Web of Science ®Google Scholar
• ScherrPAHebertLESmithLARelation of blood pressure to cognitive function in the elderlyAm J Epidemiol19911341303151755444
   PubMed Web of Science ®Google Scholar
• Schnaider BeeriMGoldbourtUSilvermanJMDiabetes mellitus in midlife and the risk of dementia three decades laterNeurology2004631902715557509
   PubMed Web of Science ®Google Scholar
• SeuxMLThijsLForetteFCorrelates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia ProjectJ Hypertens19981696399794736
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA19912653255642046107
   PubMed Web of Science ®Google Scholar
• ShepherdJBlauwGJMurphyMBPROSPER study groupPROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialLancet200236016233012457784
   PubMed Web of Science ®Google Scholar
• ShintonRBeeversGMeta-analysis of relation between cigarette smoking and strokeBMJ1989298789942496858
   PubMed Web of Science ®Google Scholar
• ShobabLAHsiungGYFeldmanHHCholesterol in Alzheimer’s diseaseLancet Neurol200548415216297842
   PubMed Web of Science ®Google Scholar
• SimonsMKellerPDe StrooperBCholesterol depletion inhibits the generation of beta-amyloid in hippocampal neuronsProc Natl Acad Sci USA199895646049600988
   PubMed Web of Science ®Google Scholar
• SkoogILernfeltBLandahlS15-year longitudinal study of blood pressure and dementiaLancet1996347114158609748
   PubMed Web of Science ®Google Scholar
• SkoogILithellHHanssonLSCOPE Study GroupEffect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)Am J Hypertens2005181052916109319
   PubMed Web of Science ®Google Scholar
• SnowdonDAGreinerLHMortimerJABrain infarction and the clinical expression of Alzheimer disease. The Nun StudyJAMA199727781379052711
   PubMed Web of Science ®Google Scholar
• SolfrizziVPanzaFD’IntronoALipoprotein (a), apolipoprotein E genotype, and risk of Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry200272732612023414
   PubMed Web of Science ®Google Scholar
• SolfrizziVPanzaFColaciccoAMItalian Longitudinal Study on Aging Working GroupVascular risk factors, incidence of MCI, and rates of progression to dementiaNeurology20046318829115557506
   PubMed Web of Science ®Google Scholar
• SparksDLScheffSWHunsakerJCInduction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterolExp Neurol199412688948157129
   PubMed Web of Science ®Google Scholar
• SparksDLSabbaghMNConnorDJAtorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resultsArch Neurol200562753715883262
   PubMed Web of Science ®Google Scholar
• StarrJMWhalleyLJInchSBlood pressure and cognitive function in healthy old peopleJ Am Geriatr Soc19934175368315187
   PubMed Web of Science ®Google Scholar
• StarrJMWhalleyLJDearyIJThe effects of antihypertensive treatment on cognitive function: results from the HOPE studyJ Am Geriatr Soc19964441158636587
   PubMed Web of Science ®Google Scholar
• StarrJMDearyIJInchSBlood pressure and cognitive decline in healthy old peopleJ Hum Hypertens199711777819468003
   PubMed Web of Science ®Google Scholar
• SteinbergDAtherogenesis in perspective: hypercholesterolemia and inflammation as partners in crimeNat Med200281211712411947
   PubMed Web of Science ®Google Scholar
• StegmayerBAsplundKDiabetes as a risk factor for stroke. A population perspectiveDiabetologia199538106188591820
   PubMed Web of Science ®Google Scholar
• SwanGECarmelliDLarueASystolic blood pressure tracking over 25 to 30 years and cognitive performance in older adultsStroke1998a292334409804644
   PubMed Web of Science ®Google Scholar
• SwanGEDeCarliCMillerBLAssociation of midlife blood pressure to late-life cognitive decline and brain morphologyNeurology1998b51986939781518
   PubMed Web of Science ®Google Scholar
• TanZSSeshadriSBeiserAPlasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham StudyArch Intern Med20031631053712742802
   PubMed Web of Science ®Google Scholar
• ThomasTThomasGMcLendonCbeta-Amyloid-mediated vasoactivity and vascular endothelial damageNature1996380168718600393
   PubMed Web of Science ®Google Scholar
• TilvisRSKähönen-VäreMHJolkkonenJPredictors of cognitive decline and mortality of aged people over a 10-year periodJ Gerontol A Biol Sci Med Sci2004592687415031312
   PubMed Web of Science ®Google Scholar
• TyasSLWhiteLRPetrovitchHMid-life smoking and late-life dementia: the Honolulu-Asia Aging StudyNeurobiol Aging2003245899612714116
   PubMed Web of Science ®Google Scholar
• TzourioCDufouilCDucimetierePCognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular AgingNeurology19995319485210599763
   PubMed Web of Science ®Google Scholar
• TzourioCAndersonCChapmanNPROGRESS Collaborative GroupEffects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular diseaseArch Intern Med200316310697512742805
   PubMed Web of Science ®Google Scholar
• VagnucciAHJrLiWWAlzheimer’s disease and angiogenesisLancet2003361605812598159
   PubMed Web of Science ®Google Scholar
• VanhanenMKoivistoKMoilanenLAssociation of metabolic syndrome with Alzheimer disease: a population-based studyNeurology200667843716966548
   PubMed Web of Science ®Google Scholar
• van OijenMde JongFJWittemanJCAtherosclerosis and risk for dementiaAnn Neurol2007614031017328068
   PubMed Web of Science ®Google Scholar
• VergheseJLiptonRBHallCBLow blood pressure and the risk of dementia in very old individualsNeurology20036116677214694027
   PubMed Web of Science ®Google Scholar
• VictoroffJMackWJLynessSAMulticenter clinicopathological correlation in dementiaAm J Psychiatry19951521476847573587
   PubMed Web of Science ®Google Scholar
• WaldsteinSRRiceSCThayerJFPulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of AgingHypertension20071119
   PubMed Web of Science ®Google Scholar
• WangSYWeight loss and metabolic changes in dementiaJ Nutr Health Aging20026201511887245
   PubMedGoogle Scholar
• WhiteHPieperCSchmaderKWeight change in Alzheimer’s diseaseJ Am Geriatr Soc199644265728600194
   PubMed Web of Science ®Google Scholar
• WhitehousePJSciulliCGMasonRMDementia drug development: use of information systems to harmonize global drug developmentPsychopharmacol Bull199733129339133764
   PubMedGoogle Scholar
• WhitmerRASidneySSelbyJMidlife cardiovascular risk factors and risk of dementia in late lifeNeurology2005642778115668425
   PubMed Web of Science ®Google Scholar
• WhitmerRAGundersonEPBarrett-ConnorEObesity in middle age and future risk of dementia: a 27 year longitudinal population based studyBMJ2005330136015863436
   PubMed Web of Science ®Google Scholar
• WhitmerRAThe epidemiology of adiposity and dementiaCurr Alzheimer Res200741172217430233
   PubMed Web of Science ®Google Scholar
• WilsonPWSchaeferEJLarsonMGApolipoprotein E alleles and risk of coronary disease. A meta-analysisArterioscler Thromb Vasc Biol199616125058857921
   PubMed Web of Science ®Google Scholar
• WolozinBKellmanWRuosseauPDecreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitorsArch Neurol20005714394311030795
   PubMed Web of Science ®Google Scholar
• WolozinBCholesterol, statins and dementiaCurr Opin Lipidol2004156677215529026
   PubMed Web of Science ®Google Scholar
• XuWLQiuCXWahlinADiabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up studyNeurology2004631181615477535
   PubMed Web of Science ®Google Scholar
• XuWQiuCWinbladBThe effect of borderline diabetes on the risk of dementia and Alzheimer’s diseaseDiabetes200756211617192484
   PubMed Web of Science ®Google Scholar
• YaffeKKanayaALindquistKThe metabolic syndrome, inflammation, and risk of cognitive declineJAMA200429222374215536110
   PubMed Web of Science ®Google Scholar
• YaffeKBlackwellTWhitmerRAGlycosylated hemoglobin level and development of mild cognitive impairment or dementia in older womenJ Nutr Health Aging200610293516886099
   PubMed Web of Science ®Google Scholar
• YaffeKMetabolic Syndrome and Cognitive Disorders: Is the Sum Greater Than Its Parts?Alzheimer Dis Assoc Disord2007211677117545744
   PubMed Web of Science ®Google Scholar
• YaffeKHaanMBlackwellTMetabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging studyJ Am Geriatr Soc2007557586217493197
   PubMed Web of Science ®Google Scholar
• YamadaMKasagiFSasakiHAssociation between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health StudyJ Am Geriatr Soc200351410412588587
   PubMed Web of Science ®Google Scholar
• YanagisawaKCholesterol and pathological processes in Alzheimer’s diseaseJ Neurosci Res200270361612391598
   PubMed Web of Science ®Google Scholar
• YoshitakeTKiyoharaYKatoIIncidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama StudyNeurology199545116187783883
   PubMed Web of Science ®Google Scholar
• YoungSEMainousAGCarnemollaMHyperinsulinemia and cognitive decline in a middle-aged cohortDiabetes Care20062926889317130206
   PubMed Web of Science ®Google Scholar
• ZamriniEMcGwinGRosemanJMAssociation between statin use and Alzheimer’s diseaseNeuroepidemiology20042394814739574
   PubMed Web of Science ®Google Scholar
• ZandiPPSparksDLKhachaturianASCache County Study investigatorsDo statins reduce risk of incident dementia and Alzheimer disease? The Cache County StudyArch Gen Psychiatry2005622172415699299
   PubMed Web of Science ®Google Scholar
• ZhuLViitanenMGuoZBlood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-upJ Clin Epidemiol199851385919619965
   PubMed Web of Science ®Google Scholar
• ZuccalàGOnderGPedoneCHypotension and cognitive impairment: Selective association in patients with heart failureNeurology20015719869211739814
   PubMed Web of Science ®Google Scholar
• ZuccalàGOnderGMarzettiEUse of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failureEur Heart J2005262263315618043
   PubMed Web of Science ®Google Scholar